Ardent Health Partners’ (ARDT) “Overweight” Rating Reaffirmed at Stephens

Ardent Health Partners (NYSE:ARDT)‘s stock had its “overweight” rating reaffirmed by Stephens in a research report issued on Thursday,Benzinga reports. They currently have a $22.00 price target on the stock. Stephens’ price objective indicates a potential upside of 42.86% from the company’s previous close.

A number of other analysts have also recently issued reports on ARDT. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, January 21st. Finally, Truist Financial decreased their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus target price of $21.36.

Ardent Health Partners Price Performance

NYSE ARDT opened at $15.40 on Thursday. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The firm’s fifty day moving average price is $15.29 and its two-hundred day moving average price is $16.87. Ardent Health Partners has a 1 year low of $13.63 and a 1 year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last issued its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion. Equities research analysts expect that Ardent Health Partners will post 1.23 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Ardent Health Partners during the fourth quarter worth approximately $27,000. US Bancorp DE bought a new position in shares of Ardent Health Partners in the fourth quarter worth $31,000. R Squared Ltd bought a new position in shares of Ardent Health Partners in the fourth quarter worth $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners in the third quarter valued at about $42,000. Finally, New York State Common Retirement Fund bought a new stake in Ardent Health Partners during the fourth quarter worth about $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.